Home Categories API PolymyxinBsulfate
A7608558

PolymyxinBsulfate , 10mMinWater , 1405-20-5

Synonym(s):
Polymyxin B sulfate;Polymixin B;Bacillus Cereus;Polymixin;Aerosporin

CAS NO.:1405-20-5

Empirical Formula: C56H100N16O17S

Molecular Weight: 1301.56

MDL number: MFCD30489731

EINECS: 215-774-7

Pack Size Price Stock Quantity
1ml RMB159.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 217-220°C (dec.)
storage temp.  2-8°C
solubility  H2O: 50 mg/mL
form  powder
pka pKa 8.9 (Uncertain)
color  colorless or slightly yellow
PH pH (10g/L, 25℃) : 4.5~7.0
optical activity [α]/D 20/D (Rotation: -2.3 +/- 0.2 degrees)
Water Solubility  Soluble in water at 50mg/ml/n
Merck  14,7573
Stability: Hygroscopic
InChIKey HFMDLUQUEXNBOP-UHFFFAOYSA-N
LogP -6.361 (est)
CAS DataBase Reference 1405-20-5(CAS DataBase Reference)
EPA Substance Registry System Polymixin B sulfate (1405-20-5)

Description and Uses

The polymyxins are cationic peptides originally isolated from B. polymyxa. They bind and kill Gram-negative bacteria. The B series of polymyxins consist of a cyclic heptapeptide and a tripeptide side chain acylated at the amino terminus by a fatty acid. Polymyxin B (sulfate) is a mixture of at least four closely related components, polymyxin B1 to B4, with polymyxin B1 and B2 being the two major components. Polymyxin B (sulfate) has rapid in vitro bactericidal activity against major multidrug-resistant Gram-negative bacteria, such as P. aeruginosa, A. baumannii, and K. pneumoniae.

Polymyxin B sulfate is used as topical antibiotic agent, often used in combination with neomycin; products include ointments, creams, eye, and ear drops.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P264-P270-P301+P312-P501
Hazard Codes  Xn
Risk Statements  22
Safety Statements  22-24/25
RIDADR  3249
WGK Germany  3
RTECS  TR1150000
3-8-10
HS Code  2941 90 00
HazardClass  6.1(b)
PackingGroup  III
Toxicity dog,LDLo,intracrebral,320ug/kg (0.32mg/kg),BEHAVIORAL: COMA,British Journal of Pharmacology and Chemotherapy. Vol. 23, Pg. 552, 1964.

RELATED PRODUCTS